Evidence Hub

Intrinsic Near-Infrared-II Fluorescent Nanozymes Support High-Resolution Imaging and Tumor Catalytic Immunotherapy

Yang F, Zhang D, Liu K, Cao X, Liu D, Liang Y, Chen M, Lin H et al.

Angewandte Chemie (International ed. in English), 2026

Abstract

Nanozymes hold considerable promise for in vivo therapy due to their stable and versatile enzyme-mimicking activities. However, real-time tracking of their dynamics with high spatiotemporal resolution and ensuring biosafety remain challenging. Here, we report a class of single-component, metal-free autofluorescent nanozymes (AFNZs) that simultaneously exhibit ultrabright second near-infrared (NIR-II) fluorescence (FL) and potent multienzyme-like activities. By precisely controlling sulfur/nitrogen (S/N) stoichiometry during the solvothermal conversion of cyanine precursors, we developed intrinsically emissive nanozymes with high-brightness NIR-II FL (quantum yield >1.4%, maximum emission wavelength >1100 nm) among metal-free nanozyme systems, achieving a 20-fold enhancement over their precursors. The optimized AFNZs exhibit strong peroxidase (POD)-, catalase (CAT)-, and oxidase (OXD)-like activities, enabling high-contrast in vivo imaging and catalytic tumor therapy. Mechanistic studies suggest that the enhanced FL is associated with restricted intramolecular motion (RIM). These nanozymes support deep-tissue tumor imaging (∼8 mm) and high-resolution angiography (∼30 µm), substantially outperforming their precursors and the clinical contrast agent indocyanine green (ICG). Furthermore, they enable precise tumor margin identification, image-guided resection of microtumors (< 5 mm), and real-time monitoring of catalytic immunotherapy associated with autophagic flux disruption…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free